The Reliability of Vardenafil for Erectile Dysfunction II (RELY II) Trial.The Reliability of Vardenafil for Erectile Dysfunction Erectile Dysfunction Definition Erectile dysfunction (ED), formerly known as impotence, is the inability to achieve or maintain an erection long enough to engage in sexual intercourse. II (RELY II) Trial, Luc Valiquette, Hopital St.-Luc du CHUM, Canada; Francesco Montorsi, Universita Vita Salute San Raffaele San Raffaele may refer to:
We evaluated the percent of subsequent successful doses with vardenafil 20 mg after an initial vardenafil response. In this double-blind, multicenter study, 573 men with erectile dysfunction (ED) for more than 6 months were challenged with a single dose of vardenafil 20 mg; those achieving successful penetration were randomized ran·dom·ize tr.v. ran·dom·ized, ran·dom·iz·ing, ran·dom·iz·es To make random in arrangement, especially in order to control the variables in an experiment. to vardenafil 20 mg or placebo for 12 weeks. The primary endpoint, penetration (SEP 1. SEP - Someone Else's Problem. 2. (tool) SEP - A SASD tool from IDE. 2) reliability, was calculated as percentage of successful doses within 12 hours of dosing over total valid doses. Secondary endpoints included completion of intercourse INTERCOURSE. Communication; commerce; connexion by reciprocal dealings between persons or nations, as by interchange of commodities, treaties, contracts, or letters. (SEP3) reliability, calculated as percentage of successful doses over total valid doses, for the subset A group of commands or functions that do not include all the capabilities of the original specification. Software or hardware components designed for the subset will also work with the original. of subjects having both successful penetration and successful completion of intercourse during the challenge. Of 573 men, 81% achieved successful penetration with the challenge dose and were randomized to vardenafil 01 = 230) or placebo (n = 233). Most men had severe (34%) or moderate (35%) ED, and many had comorbid conditions, such as hypertension hypertension or high blood pressure, elevated blood pressure resulting from an increase in the amount of blood pumped by the heart or from increased resistance to the flow of blood through the small arterial blood vessels (arterioles). , dyslipidemia, and diabetes. Following initial success, mean per-patient penetration reliability rate for vardenafil over Weeks 0-12 was 85% vs. 45% for placebo. Seventy percent also achieved initial successful completion of intercourse with the challenge dose. Following initial success of intercourse completion, the mean per-patient intercourse completion reliability rate for vardenafil over Weeks 0-12 was 78% vs. 29% for placebo. Vardenafil was generally well-tolerated. Overall, vardenafil provided reliable efficacy for patients with ED, on first-time dosing as well as on further occasions. |
|
||||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion